BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24633194)

  • 21. Application of clonal analysis. Differential diagnosis for synchronous primary ovarian and endometrial cancers and metastatic cancer.
    Fujita M; Enomoto T; Wada H; Inoue M; Okudaira Y; Shroyer KR
    Am J Clin Pathol; 1996 Mar; 105(3):350-9. PubMed ID: 8602617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synchronous Endometrial and Ovarian Carcinomas: Evidence of Clonality.
    Anglesio MS; Wang YK; Maassen M; Horlings HM; Bashashati A; Senz J; Mackenzie R; Grewal DS; Li-Chang H; Karnezis AN; Sheffield BS; McConechy MK; Kommoss F; Taran FA; Staebler A; Shah SP; Wallwiener D; Brucker S; Gilks CB; Kommoss S; Huntsman DG
    J Natl Cancer Inst; 2016 Jun; 108(6):djv428. PubMed ID: 26832771
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence of microsatellite instability in synchronous tumors of the ovary and endometrium.
    Shannon C; Kirk J; Barnetson R; Evans J; Schnitzler M; Quinn M; Hacker N; Crandon A; Harnett P
    Clin Cancer Res; 2003 Apr; 9(4):1387-92. PubMed ID: 12684409
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Women with synchronous primary cancers of the endometrium and ovary: do they have Lynch syndrome?
    Soliman PT; Broaddus RR; Schmeler KM; Daniels MS; Gonzalez D; Slomovitz BM; Gershenson DM; Lu KH
    J Clin Oncol; 2005 Dec; 23(36):9344-50. PubMed ID: 16361634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mitochondrial DNA analysis efficiently contributes to the identification of metastatic contralateral breast cancers.
    Girolimetti G; Marchio L; De Leo A; Mangiarelli M; Amato LB; Zanotti S; Taffurelli M; Santini D; Gasparre G; Ceccarelli C
    J Cancer Res Clin Oncol; 2021 Feb; 147(2):507-516. PubMed ID: 33236215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Strategies for Lynch syndrome identification in selected and unselected gynecological cancers.
    Carnevali I; Sahnane N; Chiaravalli AM; Di Lauro E; Facco C; Facchi S; Casarin J; Ghezzi F; Sessa F; Tibiletti MG
    Eur J Cancer Prev; 2022 Jul; 31(4):369-376. PubMed ID: 34519692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tracking the origin of simultaneous endometrial and ovarian cancer by next-generation sequencing - a case report.
    Valtcheva N; Lang FM; Noske A; Samartzis EP; Schmidt AM; Bellini E; Fink D; Moch H; Rechsteiner M; Dedes KJ; Wild PJ
    BMC Cancer; 2017 Jan; 17(1):66. PubMed ID: 28103826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synchronous endometrioid carcinomas of the uterine corpus and ovary: alterations in the beta-catenin (CTNNB1) pathway are associated with independent primary tumors and favorable prognosis.
    Irving JA; Catasús L; Gallardo A; Bussaglia E; Romero M; Matias-Guiu X; Prat J
    Hum Pathol; 2005 Jun; 36(6):605-19. PubMed ID: 16021566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preoperative identification of synchronous ovarian and endometrial cancers: the importance of appropriate workup.
    Broeders FM; van der Wurff AA; Pijnenborg JM; Vos MC
    Int J Gynecol Cancer; 2012 Oct; 22(8):1325-31. PubMed ID: 22968517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Massively Parallel Sequencing-Based Clonality Analysis of Synchronous Endometrioid Endometrial and Ovarian Carcinomas.
    Schultheis AM; Ng CK; De Filippo MR; Piscuoglio S; Macedo GS; Gatius S; Perez Mies B; Soslow RA; Lim RS; Viale A; Huberman KH; Palacios JC; Reis-Filho JS; Matias-Guiu X; Weigelt B
    J Natl Cancer Inst; 2016 Jun; 108(6):djv427. PubMed ID: 26832770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of microsatellite instability in the distinction between synchronous endometrial and colonic adenocarcinomas.
    Krebs PA; Albuquerque A; Quezado M; Bryant B; Sobel ME; Merino MJ; Otis CN
    Int J Gynecol Pathol; 1999 Oct; 18(4):320-4. PubMed ID: 10542939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synchronous Endometrial and Ovarian Cancer in Young Women: Case Report and Review of the Literature.
    Dogan A; Schultheis B; Rezniczek GA; Hilal Z; Cetin C; Häusler G; Tempfer CB
    Anticancer Res; 2017 Mar; 37(3):969-978. PubMed ID: 28314254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synchronous primary cancers of endometrium and ovary vs endometrial cancer with ovarian metastasis: an observational study.
    Moro F; Leombroni M; Pasciuto T; Trivellizzi IN; Mascilini F; Ciccarone F; Zannoni GF; Fanfani F; Scambia G; Testa AC
    Ultrasound Obstet Gynecol; 2019 Jun; 53(6):827-835. PubMed ID: 30620432
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synchronous primary endometrial and ovarian cancer with three different histologic patterns: A case report.
    Ree YS; Cho SH; Kim SR; Cho SH; Kim KT; Park MH
    Int J Gynecol Cancer; 2003; 13(5):678-82. PubMed ID: 14675354
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CTNNB1 p.L31P mutation in an ovarian endometrioid carcinoma with synchronous uterine endometrioid carcinoma.
    Pecorella I; Coppa A; Nicolussi A; Manganaro L; Fiorentin F; Palaia I; Muzii L
    Pathol Res Pract; 2020 Dec; 216(12):153260. PubMed ID: 33120166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetics of synchronous uterine and ovarian endometrioid carcinoma: combined analyses of loss of heterozygosity, PTEN mutation, and microsatellite instability.
    Fujii H; Matsumoto T; Yoshida M; Furugen Y; Takagaki T; Iwabuchi K; Nakata Y; Takagi Y; Moriya T; Ohtsuji N; Ohtsuji M; Hirose S; Shirai T
    Hum Pathol; 2002 Apr; 33(4):421-8. PubMed ID: 12055677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of heterozygosity and genomic instability in synchronous endometrioid tumors of the ovary and endometrium.
    Shenson DL; Gallion HH; Powell DE; Pieretti M
    Cancer; 1995 Aug; 76(4):650-7. PubMed ID: 8625160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinicopathologic insight of simultaneously detected primary endometrial and ovarian carcinomas.
    Rodolakis A; Thomakos N; Akrivos N; Sotiropoulou M; Ioannidis I; Haidopoulos D; Vlachos G; Antsaklis A
    Arch Gynecol Obstet; 2012 Mar; 285(3):817-21. PubMed ID: 21842403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endometrial carcinomas in women aged 40 years and younger: tumors associated with loss of DNA mismatch repair proteins comprise a distinct clinicopathologic subset.
    Garg K; Shih K; Barakat R; Zhou Q; Iasonos A; Soslow RA
    Am J Surg Pathol; 2009 Dec; 33(12):1869-77. PubMed ID: 19898223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simultaneous carcinoma of the endometrium and ovary vs endometrial carcinoma with ovarian metastases: a clinical and immunohistochemical determination.
    Halperin R; Zehavi S; Hadas E; Habler L; Bukovsky I; Schneider D
    Int J Gynecol Cancer; 2003; 13(1):32-7. PubMed ID: 12631217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.